Top-News
Professionelle Dienstleistungen USA

Champions Oncology News

Aktie
WKN:  A14X6S ISIN:  US15870P3073 US-Symbol:  CSBR
4,16 €
-0,04 €
-0,95%
16.05.24 18:04:34
Handeln Depot/Watchlist
Aktienanzahl *
13,56 Mio.
Marktkapitalisierung *
58,18 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.07.2023

Champions Oncology News

02.11.23 - IRW-Press
Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung
HACKENSACK, New Jersey / ACCESSWIRE / 2. November 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), ein international tätiger Dienst­leister im Bereich der präklinischen ...
08.09.22 - ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
HACKENSACK, NJ / ACCESSWIRE / September 8, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-​enabled biotech that is transforming drug ...
21.07.22 - ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
Record Annual Revenue of $49.1 Million
14.07.22 - ACCESSWIRE
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-​enabled biotech that is transforming drug discovery through ...
31.05.22 - ACCESSWIRE
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-​enabled biotech that is ...
03.05.22 - ACCESSWIRE
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
HACKENSACK, NJ / ACCESSWIRE / May 3, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-​enabled biotech that is transforming drug discovery ...
15.03.22 - ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-​enabled biotech that is transforming drug discovery ...
11.03.22 - ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-​enabled biotech that is transforming drug discovery through ...
15.02.22 - ACCESSWIRE
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
HACKENSACK, NJ / ACCESSWIRE / February 15, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-​enabled biotech that is transforming drug ...
20.01.22 - ACCESSWIRE
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-​enabled biotech that is transforming drug ...
04.01.22 - ACCESSWIRE
Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-​enabled biotech that is transforming drug discovery ...
13.12.21 - ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
Reported income from operations of $263,000
06.12.21 - ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug ...
20.10.21 - ACCESSWIRE
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-​enabled research organization announced the opening of a European ...
13.09.21 - ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and ...
02.09.21 - ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and ...
26.07.21 - ACCESSWIRE
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug ...
22.07.21 - ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $10.6 Million
Record Annual Revenue of $41 Million
14.07.21 - ACCESSWIRE
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming ...
15.06.21 - ACCESSWIRE
Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-​enabled research organization announced today that they have entered ...

Newssuche

Videos

newspaper
14.05.24 -16,04%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »